CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Return 24.98%
This Quarter Return
+17.27%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
AUM
$1.31B
AUM Growth
-$34.2M
Cap. Flow
-$55.6M
Cap. Flow %
-4.24%
Top 10 Hldgs %
77.05%
Holding
39
New
3
Increased
8
Reduced
5
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CTNM
26
Contineum Therapeutics
CTNM
$322M
$5.22M 0.4%
+296,666
New +$5.22M
KYTX icon
27
Kyverna Therapeutics
KYTX
$170M
$4.31M 0.33%
575,000
+425,000
+283% +$3.19M
SNDX icon
28
Syndax Pharmaceuticals
SNDX
$1.47B
$3.08M 0.24%
150,000
ABSI icon
29
Absci
ABSI
$368M
$3M 0.23%
973,260
GH icon
30
Guardant Health
GH
$7.5B
$2.89M 0.22%
+100,000
New +$2.89M
PRME icon
31
Prime Medicine
PRME
$663M
$1.89M 0.14%
367,175
PACB icon
32
Pacific Biosciences
PACB
$381M
$1.42M 0.11%
1,035,859
GRAL
33
GRAIL, Inc. Common Stock
GRAL
$1.33B
$1.23M 0.09%
+79,999
New +$1.23M
EXAI
34
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$1.09M 0.08%
213,900
GLUE icon
35
Monte Rosa Therapeutics
GLUE
$305M
$976K 0.07%
261,014
-249,868
-49% -$935K
DNA icon
36
Ginkgo Bioworks
DNA
$660M
$488K 0.04%
36,494
OMIC
37
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$373K 0.03%
44,129
-1
-0% -$8
KRON
38
DELISTED
Kronos Bio
KRON
$154K 0.01%
123,839
ABCL icon
39
AbCellera Biologics
ABCL
$1.26B
-2,360,129
Closed -$10.7M